DexCom Inc logo

DexCom Inc

€ 90.65 (+1.57%) Aug 16
On watch
P/E:
188.75
P/B:
15.80
Market Cap:
€ 34.81B ($ 35.37B)
Enterprise V:
€ 34.20B ($ 34.75B)
Volume:
141.00
Avg Vol (2M):
159.00
Also Trade In:
Volume:
141.00
Market Cap €:
34.81B
Market Cap $:
35.37B
PE Ratio:
188.75
Avg Vol (2-Month):
159.00
Enterprise Value €:
34.20B
Enterprise Value $:
34.75B
PB Ratio:
15.80
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

DexCom Inc
NAICS : 325413 SIC : 5047
6340 Sequence Drive, San Diego, CA, USA, 92121
Description
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Name Current Vs Industry Vs History
Cash-To-Debt 1.29
Equity-to-Asset 0.43
Debt-to-Equity 0.95
Debt-to-EBITDA 5.52
Interest Coverage 3.88
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.6
Distress
Grey
Safe
Beneish M-Score -2.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 68.26
9-Day RSI 63.08
14-Day RSI 61.23
6-1 Month Momentum % -13.25
12-1 Month Momentum % -24.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.72
Quick Ratio 4.3
Cash Ratio 3.41
Days Inventory 137.7
Days Sales Outstanding 71.87
Days Payable 75.84

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.5

Financials (Next Earnings Date:2022-10-28 Est.)

WBO:DXCM's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 2,400.133
EPS (TTM) (€) 0.432
Beta 0
Volatility % 50.04
14-Day RSI 61.23
14-Day ATR (€) 2.910418
20-Day SMA (€) 84.865
12-1 Month Momentum % -24.86
52-Week Range (€) 64.81 - 144.7
Shares Outstanding (Mil) 389.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

DexCom Inc Filings

Document Form Filing Date
No Filing Data